Publication:
Melatonin Makes Me Feel Awake! Seven Years of Lab Experience (2000-2007)

Loading...
Thumbnail Image
Full text at PDC
Publication Date
2007
Authors
Pelaez, Teresa
Mediero Muñoz, Aránzazu
Alarma-Estrany, Pilar
Loma Lozano, Patricia
Crooke, Almudena
Kolligris, Basilio
Peral Cerdá, Assumpta
Pintor, Jesús
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Real Academia Nacional de Farmacia
Citations
Google Scholar
Research Projects
Organizational Units
Journal Issue
Abstract
The research on the effect of melatonin on intraocular pressure (IOP) is reviewed from the hystorical point of view of our laboratory. The original idea of melatonin modulating intraocular pressure has been improved by using selective compounds for MT2 and specially melatonin MT3 receptors. The selective compound 5-methoxyamino N-acetyltryptamine (5-MCA-NAT) has been an attractive compound due to its ability to reduce IOP about 40%, therefore being a good candidate to the treatment of the ocular hypertension linked to glaucoma. More compounds have been developed and tested permitting us to have a more accurate panorama of those receptors controlling the relevant process of intraocular pressure.
La investigación sobre el efecto de la melatonina sobre la presión intraocular (PIO) es revisada desde la perspectiva histórica de nuestro laboratorio. La idea original sobre la melatonina modulando la presión intraocular ha sido mejorada gracias al empleo de nuevos compuestos selectivos para el receptor MT2 y especialmente para el MT3. El compuesto selectivo 5-metoxiamino N-acetiltriptamina (5-MCA-NAT) se ha convertido en un compuesto muy atractivo debido a su capacidad de reducir la PIO hasta un 50%, convirtiéndose en un compuesto muy interesante para el tratamiento de la hipertensión ocular asociada al glaucoma. Se han desarrollado y ensayado más compuestos que nos han permitido tener un panorama más preciso acerca de como estos receptores controlan el proceso fisiológico de la presión intraocular.
Description
En O.A. en la web del editor
Keywords
Citation
(1) PINTOR, J. AND PERAL, A. (2001) Therapeutic potential of nucleotides in the eye. Drug Dev. Res. 52: 190-195. (2) MOLINARI, E.J.; NORTH, P.C. AND DUBOCOVICH, M.L. (1996) 2-[125I]Iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur. J. Pharmacol. 301: 159-168. (3) PINTOR, J.; MARTIN, L.; PELAEZ, T.; HOYLE C.H.V. AND PERAL, A. (2001) Involvement of melatonin MT3 receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol. 416: 251-254. (4) Weinreb R.N. and Khaw P.T. (2004) Primary open-angle glaucoma. The Lancet. 363:1711-1720. (5) PINTOR, J. (2005) Nuevas perspectivas farmacológicas de la melatonina en el tratamiento de las patologías oculares. An. R. Acad. Nac. Farm. 71: 429-438. (6) PINTOR, J.; PELAEZ, T.; HOYLE C.H.V. AND PERAL, A. (2003) Ocular hypotensive effect of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. Brit. J. Pharmacol. 138: 831-836. (7) SERLE, J.B.; WANG, R.-F.; PETERSON, W.M.; PLOURDE R. AND YERXA, B.R. (2004) Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist on intraocular pressure in glaucomatous monkeys eyes. J. Glaucoma. 13: 385-388. (8) ALARMA-ESTRANY, P.; CROOKE, A.; PERAL, A. AND PINTOR, J. (2007) Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Auton. Neurosc.: Basic and Clinical. In press. (9) PINTOR, J.; CARRACEDO, G.; MEDIERO, A.; GUZMAN-ARANGUEZ, A.; IRAZU, M.; PELAEZ, T. AND PERAL, A. (2005) Melatonin increases the rate of re-epithelialization in New Zealand white rabbits. Invest. Ophthalmol. Vis. Sci. 46: A2152. (10) HOYLE, C.H.V.; PERAL, A. AND PINTOR, J. (2006) Melatonin potentiates tear secretion induced by diadenosine tetraphosphate in the rabbit. Eur. J. Pharmacol. 552: 159-161. (11) NOSJEAN, O.; NICOLAS, J.-P.; KLUPSCH, F.; DELAGRANGE, P.; CANET E. AND BOUTIN, J. A. (2001) Comparative pharmacological studies of melatonin receptors: mt1, mt2 and mt3/qr2. Tissue distribution of mt3/qr2. Biochem. Pharmacol. 61: 1369-1379. (12) MAILLIET, F.; FERRY, G.; VELLA, F.; THIAM, K.; DELAGRANGE P. AND BOUTIN, J.A. (2004) Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. FEBS Lett. 578: 116-120. (13) MULLINS, U.L.; FERNANDES, P.B. AND EISON, A.S. (1997) Melatonin Agonists Induce Phosphoinositide Hydrolysis in Xenopus laevis Melanophores. Cell. Signal. 9: 169-173. (14) ALARMA-ESTRANY, P. AND PINTOR, J. (2007) Melatonin receptors in the eye: Location, second messengers and role in ocular physiology. Pharmacol. Ther. 113: 507-522. (15) DUBOCOVICH, M.L. (1995) Melatonin receptors: Are there multiple subtypes?, Trends Pharmacol. Sci. 16: 50-56. (16) REPPERT, S.M.; WEAVER, D.R. AND EBISAWA, T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron. 13: 1177-1185. (17) REPPERT, S.M.; WEAVER, D.R.; EBISAWA, T.; MAHLE, C.D. AND KOLAKOWSKI, L.F. (1996) Cloning of a melatonin-related receptor from human pituitary. FEBS Letts. 386: 219-224. (18) NOSJEAN, O.; FERRO, M.; COGE, F.; BEAUVERGER, P.; HENLIN, J.; LEFOULON, F. AND DELAGRANGE, P. (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2. J. Biol. Chem. 275: 31311-31317. (19) NAVAJAS, C.; KOKKOLA, T.; POSO, A.; HONKA, N.; GYNTHER, J. AND LAITINEN, J.T. (1996) A rhodopsin-based model for melatonin recognition at its G proteincoupled receptor. Eur. J. Pharmacol. 304: 173-183. (20) REPPERT, S.M.; WEAVER, D.R.; CASSONE, V.M.; GODSON, C. AND KOLAKOWSKI, J.L.F. (1995) Melatonin receptors are for the birds: Molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron. 15: 1003-1015. (21) SLAUGENHAUPT, S.A.; ROCA, A.L.; LIEBERT, C.B.; ALTHERR, M.R.; GUSELLA, J.F. AND REPPERT, S.M. (1995) Mapping of the Gene for the Mel1a-Melatonin Receptor to Human Chromosome 4 (MTNR1A) and Mouse Chromosome 8 (Mtnr1a). Genomics. 27: 355-357. (22) VON GALL, C.; STEHLE, J. AND WEAVER, D.R. (2002) Mammalian melatonin receptors: Molecular biology and signal transduction. Cell Tis. Res. 309: 151-162. (23) VANECEK, J. AND KLEIN, D.C. (1995) Mechanism of melatonin signal transduction in the neonatal rat pituitary. Neurochem. Inter. 27: 273-278.
Collections